Supplemental material
Bioscience, Biotechnology, and Biochemistry
Volume 75, 2011 - Issue 8
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related Research Data
Structural Characterization of a Soluble Amyloid β-Peptide Oligomer
Source:
American Chemical Society (ACS)
Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease
Source:
Wiley
A beta oligomers - a decade of discovery.
Source:
Wiley
Amyloid- Peptide (A ) Neurotoxicity Is Modulated by the Rate of Peptide Aggregation: A Dimers and Trimers Correlate with Neurotoxicity
Source:
Society for Neuroscience
Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseases
Source:
Springer Science and Business Media LLC
INHIBITION OF Aβ42 AGGREGATION USING PEPTIDES
Source:
Wiley
Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy.
Source:
Springer Science and Business Media LLC
Soluble oligomers of β amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus
Source:
Elsevier BV
Linking provided by
